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The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the 
control.  
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages 
because growth is still exponential. 
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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(0) Executive summary – Dashboard
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Global EU+EFTA+UK trends and needs 
In 1 or 2 days, EU+EFTA+UK countries will 
reach 1 million cases. Despite the 
magnitude of this value, the number of 
diagnoses will keep increasing. Spreading 
rate ρ is fluctuating around 1, today with 
an increasing trend. The epidemic is still not 
controlled, despite the mountain chain 
shows a decreasing tendency. The 
threshold of 100,000 deaths has been 
overcome.  
The oscillations in new cases (i.e., peaks in 
the mountain chain) and, therefore, in ρ, 
show a period of 7 days. One could expect 
these oscillations to be related with 
incubation period of the disease, for 
instance, but the reason is probably much simpler: weekend effect. In many countries, a decrease in new 
cases is usually observed in weekends, despite it is observed two days later in global databases because of 
reporting delays. These oscillations are coupled and thus seen at the EU scale. The precise reasons behind 
such weekend effect should be explored. In fact, two major sources for this effect can be mentioned. First, a 
simple administrative delay on recording case data. Second, and more worrying, a worse medical attention 
in hospitals because of a decrease in sanitary workers.  
The analysis section of today’s report is focused on analysing case fatality rate (CFR) of countries and its 
relationship with lethality and with diagnosis percentage.  
Trends for specific countries 
UK is the country with a highest increase in absolute numbers, with 5,500 new cases and a high EPG. Spain 
is still leading the rank in cumulative cases, with more than 196,000, followed by Italy (almost 180,000) and 
Germany (142,000).  
There are several countries with ρ>1, while a few days ago they had ρ>1. This phenomenon is due to the 
coupled oscillations above-mentioned. If we focus on 3-day average ρ, Lithuania, Slovakia and Bulgaria show 
worrying values (4.97, 3.71 and 2.48, respectively). These countries still have low 14-day attack rate, but they 
should be closely watched out, because their situation could progress rapidly towards a critic scenario. 
Situation in Luxembourg is confusing, since they report high 14-day attack rate and a ρ of 2.09; nevertheless, 
these numbers could be related with a high percentage of diagnostic.  
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Situation and trends per country  
Table of current situation in EU countries, according to data published by ECDC on April 15th. Colour scale is 
relative except when indicated, this means that it is applied independently to each column, and distinguishes 
best (green) form worst (red) situations according to each of the variables.  
 
(1) Disclaimer: parameter ρ is very sensitive and experiments daily variations. Mean ρ is averaged per 3 consecutive days, 
but it can still vary the following days. (2) EPG stands for Effective Growth Potential. It is obtained by multiplying attack 
rate per 105 inhabitants of last 14 days (i.e. density of cases) by ρ (a value related with effective reproduction number 
and that, therefore, determines the dynamics for subsequent days). EPG2 is a similar index but attack rate of last 10 
days is multiplied by ρ2. 
 
Highlights for countries with highest number of reported cases 
 Spain is revising temporal series of a few regions. In addition, some changes in data reporting 
protocols have been made. Both issues may temporally affect Spanish data and predictions.  
 Short-term predictions for these countries are at the range of 5,500 daily new cases (UK), 3,500 
(Spain), 3,200 (Italy), 2,000 (Germany) and 1,900-1,200 (France). 
 Lowest 3-day average ρ corresponds to France (0.59), although the drastic increase in French CFR 
suggests a problem on data reporting. Remaining four countries are oscillating around 1.  
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Analysis: Case fatality rate of COVID-19 and 1% lethality as a reasonable scenario. 
Reported number of deaths per 100,000 population is a quite objective and relatively simple way of assessing 
the situation of COVID-19 epidemic in countries. The complete picture must be given by a more complex 
analysis of other data such as the number of diagnoses per 100,000 inhabitants, distribution of these cases, 
and growth rate of the epidemics, among others. Nevertheless, any analysis based on diagnosed case is 
biased by diagnosis protocols and ratios in each country, as well as by the pool of asymptomatic cases. Any 
attempt to improve diagnosis percentage requires an economic, infrastructural and logistical effort that is 
not always possible. In addition, pervious health system structure and management is a strong conditioning 
that limits possible actions to carry out in this direction. 
Nevertheless, the reported number of deaths, if uniformly and properly recorded, provides very relevant 
information as first general overview. Even in countries where there is a bias on death reporting, the effort 
that should be made to improve these data collection is much lower than the necessary effort to increase 
data about cases. However, there are some peculiarities that require reflection. Currently, the total number 
of reported deaths is normally given together with the Case Fatality Rate (CFR). This is one of the parameters 
we provide every day in one of the tables in this report by the EU+EFTA+UK. As we proceed to discuss a 
simple glance without context can be a false friend. 
A proper analysis depends very much on whether the number of reported deaths is as uniform in its criteria 
and as accurate as possible. All countries should have a special interest in knowing as much as possible about 
this information, as it can serve to give political advice and to share with the population the need for some 
of those decisions. Unfortunately, the analysis of the situation is European countries is not as solid as it could 
be since we do not have data on whether patients die in the hospital, at home or at nursing homes. It is also 
common not to have a distribution of CFR by age and sex in many countries. More importantly, there is still 
not a distinction between deaths that have been diagnosed with laboratory tests and those that have been 
diagnosed by symptomatology, if included in reports. Complete information on the death toll of the 
epidemics would allow us to give a full and better picture. Still, with the information at hand, we have 
developed a method to give a much better picture of the European situation that we will be included in the 
analyses in the next days. We start here with a general overview. 
Despite the fact that the situation has improved for all EU+EFTA+UK countries, the epidemic is far from 
over if we look at the evolution of reported deaths. Mortality can be a useful guide to roughly estimate the 
actual extent of the epidemic in the number of infected; thus, it is also interesting to have the best quality 
data available. To determine the extent of the epidemic in this case, we can compare lethality (i.e., what 
percentage of infected people die as a result of the infection) with CFR. This gives a rough idea of what 
percentage of diagnosis is, which will be the core of forthcoming reports.  
The best way to understand how this comparison can give you a back of the envelope insight is using an 
example. France and Germany, with 111,821 and 139,897 cases respectively, have similar numbers of 
reported cases (data from yesterday). These two countries have very different reported deaths, with 19,323 
in France and 4,294 in Germany. The main reason is that the level of diagnosis depends largely on the number 
of diagnostic tests performed per capita. If we consider that both countries have probably similar lethality, 
we can associate the difference in CFR with a difference in the number of tests and diagnosis. With this 
simple calculation, one can estimate that the spread of the epidemic in France is around 5 times more 
important. This is, if France were to perform as many diagnostic tests per capita as in Germany, France would 
probably have more than half a million cases. In our daily reports, we roughly estimate total attack rate of 
countries (including asymptomatic and mild cases) by assuming a 1 % lethality and comparing it with reported 
CFR, as well as a delay of 18 days before onset of the symptoms and death.  
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We must point out immediately that it is not that simple and that a more detailed analysis is required, since 
there are several factors that affect CFR and lethality. Here is a short list: 
1. The number of diagnostic tests per inhabitant. 
2. The actual number of deaths reported. In many countries, the cause of many deaths has not been 
identified and therefore not reported. This may be especially important in countries where nursing 
homes have had outbreaks of disease, which have been fatal but have not been counted because 
they have not been diagnosed. 
3. Lethality depends on the age structure of the population; in countries with a very young population, 
overall mortality can be expected to be lower. 
4. Mortality increases throughout the course of the epidemic. From the moment a person is diagnosed 
to his death, about 18 days have elapsed. Therefore, CFR starts at low values at the initial stages of 
the epidemic and progressively increases until it can reach a more or less stationary value, if other 
factors do not change. 
We can take now a look at the world and distribute the different countries according to their CFR. This figure 
gives the percentage of states that have the CFR in indicated intervals (data from yesterday). X-axis indicate 
the mean point of the considered interval (e.g., the bar above 2.5 indicates the percentage of countries with 
a current CFR between 2 % and 3 %). 
 
Using ECDC data, we can observe that at least one case has been diagnosed in all countries, but in 20% of the 
countries no death has yet been reported. Not considering these countries with no reported death, the CFR 
mode stands at 2.5%, which probably just tells us that in many states the spread of the epidemic is at an 
early stage. To date (yesterday for the reader), we find that in the world there have been 159,511 deaths for 
2,281,714 cases diagnosed, which corresponds to a CFR of 7%. The highest CFR corresponds to France with 
a CFR of 17.3%. Focusing in Europe, we have this CFR distribution among countries: 
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After France, we find a CFR>10% in the United Kingdom (13.5%), Italy (13.2%), Netherlands (11.4%), Sweden 
(10.9%) and Spain (10.4%). We find the mode again at 2.5 %.  
Finally, the following table shows the CFR for countries with more than 10,000 cases reported: 
 Total confirmed cases Total deaths CFR (%) 
USA 735,086 38,910 5.3 
Spain 191,726 20,043 10.5 
Italy 175,925 23,227 13.2 
Germany 139,897 4,294 3.1 
United Kingdom 114,217 15,464 13.5 
France 111,821 19,323 17.3 
China 83,803 4,636 5.5 
Turkey 82,329 1,890 2.3 
Iran 80,868 5,031 6.2 
Belgium 37,183 5,453 14.7 
Russia 36,793 313 0.9 
Brazil 36,599 2,347 6.4 
Canada 33,341 1,467 4.4 
Netherlands 31,589 3,601 11.4 
Switzerland 27,322 1,110 4.1 
Portugal 19,685 687 3.5 
India 15,712 507 3.2 
Ireland 14,758 571 3.9 
Austria 14,662 443 3.0 
Peru 14,420 348 2.4 
Sweden 13,822 1,511 10.9 
Israel 13,265 164 1.2 
South Korea 10,661 234 2.2 
Japan 10,361 161 1.6 
  
CFR is expected to be larger than lethality since it is not possible to detect people without symptoms in the 
first stages of the epidemic until population-wide studies are carried out. Initial reports where aleatory 
detection protocols have been carried out in Germany and Iceland point to a lethality around 0.5%. However, 
these analyses have not been done to a representative population of those infected and not in an advance 
stage of the epidemic. They might be demographically correct but are, so far, purely local. A reasonable 
middle point between the mode of CFR and preliminary analysis of random samples suggest a real lethality 
of around 1 %. Despite its uncertainty, anywhere between 0.3% and 3%, using 1% as lethality can provide 




Long-term predictions, evaluated with the whole historical series and without weighting last 3 points. Up-
left: Predictions of maximum incidences per country (total final expected attack rate per 105 inh.). Up-right: 
Predictions of maximum absolute number of cases per country (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date. See details in 
Report from 11th April 2020.  
UE-EFTA-UK countries  
 
Final expected K for UE+EFTA+UK. Evolution of predicted K with time, where convergence to best estimate 





Italian regions  
 









Situation and tendencies in Italian and Spanish regions 
Italy. Data from 19/04/2020 
 
Spain. Data from 17/04/2020  
 
(1) Disclaimer: parameter ρ is very sensitive and experiments daily variations. Mean ρ is averaged per 3 
consecutive days, but it can still vary the following days.  (2) EPG stands for Effective Growth Potential. It is 
obtained by multiplying attack rate per 105 inhabitants of last 10 days (i.e. density of cases) by ρ (a value related 
with effective reproduction number and that, therefore, determines the dynamics for subsequent days). EPG2 
is a sim 



















Mean ρ(1) EPG(2) EPG2(2)
Madrid 56,963 857.8 7,351 110.7 18,240 274.7 1.68 461.8 776.4
Catalunya 41,676 550.9 4,009 53.0 14,852 196.3 1.34 262.2 350.3
Castilla-La Mancha 16,796 825.2 2,021 99.3 7,680 377.3 1.21 454.8 548.2
Castilla y Leon 15,857 658.5 1,493 62.0 5,255 218.2 0.69 151.3 104.9
Euskadi 12,628 579.8 1,081 49.6 3,818 175.3 0.94 165.0 155.3
Andalucia 11,323 134.4 1,013 12.0 2,742 32.5 0.66 21.6 14.4
Comunitat Valenciana 10,018 201.4 1,079 21.7 2,684 54.0 0.51 27.5 14.0
Galicia 8,299 307.3 352 13.0 2,148 79.5 0.73 58.2 42.6
Aragon 4,886 369.9 637 48.2 1,539 116.5 0.99 115.6 114.7
Navarra 4,697 722.7 385 59.2 1,466 225.6 0.89 201.0 179.2
La Rioja 3,734 1,190.8 285 90.9 1,015 323.7 0.92 297.6 273.6
Extremadura 3,186 299.1 389 36.5 1,118 104.9 1.06 111.4 118.2
Asturias 2,348 229.7 200 19.6 702 68.7 0.8 51.7 38.9
Cantabria 2,083 358.1 158 27.2 600 103.1 2.29 236.6 542.6
Canarias 2,067 93.6 119 5.4 418 18.9 0.85 16.1 13.6
Baleares 1,788 150.5 157 13.2 468 39.4 2.03 79.9 161.9
Murcia 1,646 110.6 117 7.9 387 26.0 0.80 20.7 16.5
Ceuta 111 130.8 4 4.7 28 33.0 ND ND ND
Melilla 104 122.8 2 2.4 18 21.2 ND ND ND
Worst Worst Worst Worst Worst Worst 2.0 500.0 500.0




Maps of Italian and Spanish regions  









Legend: Countries’ reports details 
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale (Italy) 
 
































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 

















































Data obtained from https://github.com/datadista/datasets/tree/master/COVID%2019 and 
https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-
China/situacionActual.htm   
 
(3) Analysis and prediction of COVID-19 



























































 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale  
 
(4) Analysis and prediction of COVID-19 





















































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports1, from European Centre 
for Disease Prevention and Control (ECDC)2 and from Ministerio de Sanidad3. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 






(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model4 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          
4 Madden LV. Quantification of disease progression. Protection Ecology 1980; 2: 159-176. 
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• Group A: prediction of expected cumulated cases for the following 3-5 days5; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors6 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
5 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
6 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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